GO
Loading...

Lightning Round: MGM Mirage, Nike, Raytheon and More

MGM Mirage: Cramer said WynnResorts is beter than MGM.

Raytheon: Investors should hold on to RTN, Cramer said.

Nabi Biopharmaceuticals: NABI is a speculation play only, Cramer said.

Palm : PALM is struggling, Cramer said. Investors should by Apple instead.

GlaxoSmithKline : GSK is a buy, as is Eli Lilly , Cramer said.

FlextronicsInternational: Cramer said Flex is a buy.

Allscripts Healthcare: MDRX is a sell, Cramer said.

Coach: Cramer said COH, Nordstrom, J.Crew Group , Guess?, Nike are going higher.

Flir Systems: FLIR is a buy, as is ArcSight, Cramer said.











Cramer's charitable trust owns Apple.

Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

Symbol
Price
 
Change
%Change
COH
---
FLEX
---
FLIR
---
GES
---
GSK
---
JWN
---
LLY
---
MDRX
---
MGM
---
BOTA
---
NKE
---
RTN
---
WYNN
---
AAPL
---

Featured

Contact Mad Money

  • Showtimes

    U.S.
    Monday - Friday 6p ET
    Australia
    Saturday 8a, 1p, 7p SYD
    Sunday 12a, 1a, 8a, 7p SYD
    New Zealand
    Saturday 10a, 3p, 9p NZ
    Sunday 2a, 3a, 10a, 9p NZ
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.